Elevance Health, Inc. (ELV) Financial Statements
Historical financial data — 38 statements covering FY2016–FY2025
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and gover...
Elevance Health, Inc.'s revenue increased 12.5% year over year, from $177.01B to $199.13B.
Net income decreased 5.3% over the same period, from $5.98B to $5.66B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 135% in total.
Total debt remained relatively stable at $30.95B.
The debt-to-equity ratio stands at 0.71, indicating a moderate leverage profile.
Operating cash flow declined 26.1% to $4.29B.
Elevance Health, Inc. maintains a moderate net profit margin of 2.8%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $128.69B+49.9% | $5.13B | $116.24B | $6.71B | $11.03B | $110.48B | $24.05B | $38.42B |
| Q1 FY2024 | $42.58B-66.9% | $2.25B | $38.75B | $2.94B | $1.98B | $111.89B | $23.55B | $40.61B |
| Q2 FY2024 | $86.46B+103.1% | $4.55B | $77.82B | $5.92B | $2.42B | $112.99B | $24.79B | $42.19B |
| Q3 FY2024 | $131.57B+52.2% | $5.56B | $117.83B | $7.30B | $5.10B | $116.53B | $25.05B | $43.77B |
| Q1 FY2025 | $48.89B-62.8% | $2.18B | $43.91B | $2.80B | $1.02B | $119.72B | $28.36B | $42.50B |
| Q2 FY2025 | $98.67B+101.8% | $3.93B | $88.39B | $5.09B | $3.07B | $121.94B | $28.54B | $43.72B |
| Q3 FY2025 | $149.38B+51.4% | $5.12B | $133.72B | $6.50B | $4.21B | $122.75B | $31.35B | $43.95B |
| Q1 FY2026 | $50.18B-66.4% | $1.76B | $44.72B | $2.30B | $4.33B | $125.83B | $31.49B | $43.90B |
Balance Sheet Summary (Latest Period)
Total Assets
$121.49B
Total Liabilities
$77.47B
Total Equity
$43.88B
Cash & Equivalents
$35.38B
Total Debt
$30.95B
Current Assets
$63.00B
Current Liabilities
$41.03B
Retained Earnings
$35.39B